Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 15.66M | € 13.74M | € 8.85M | € 15.94M | € 15.54M |
Total Assets | € 195.19M | € 174.91M | € 159.89M | € 160.48M | € 158.16M |
Total Debt | € 58.45M | € 51.22M | € 43.31M | € 55.28M | € 80.59M |
Net Debt | € 42.78M | € 37.48M | € 34.46M | € 39.34M | € 65.05M |
Total Liabilities | € 151.27M | € 130.79M | € 123.29M | € 125.47M | € 125.57M |
Stockholders Equity | € 43.08M | € 43.07M | € 35.75M | € 33.92M | € 31.94M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |